Xsensio

Xsensio is a Swiss deep-tech health technology company developing wearable biochemical sensing systems for continuous, real-time patient monitoring. Its core Lab-on-Skin platform combines semiconductor-based sensing, microfluidics, and analytics to measure clinically relevant biomarkers from skin-accessible biofluids in a non-invasive or minimally invasive format. The company is initially focused on early detection of organ dysfunction and physiological deterioration in hospital and outpatient settings, including critical care, oncology, and post-surgical recovery. Xsensio appears to be operating as a platform medical-device/diagnostics company rather than a therapeutic drug developer, with clinical validation and deployment of its first products still underway. The company has raised venture financing, collaborates with clinical and industrial partners, and has highlighted work with Mayo Clinic and Texas Instruments.